Skip to main content

Table 3 Various levels of DHEAS and FAI on pregnancy outcomes

From: Impact of dehydroepiandrosterone sulfate and free androgen index on pregnancy and neonatal outcomes in PCOS patients

 

FAI < 6.4

DHEAS < 9.5 umol/l

(n = 440)

FAI > 6.4

DHEAS > 9.5 umol/l

(n = 74)

FAI > 6.4

DHEAS < 9.5 umol/l

(n = 105)

FAI < 6.4

DHEAS > 9.5 umol/l

(n = 153)

P

Clinical pregnancy rate

60.68(267/440)

37.84(28/74)

52.38(55/105)

51.63(79/153)

0.002

Multiple pregnancies rate

7.87(21/267)

17.86(5/28)

20.00(11/55)

11.39(9/79)

0.0328

Live birth rates

51.36(226/440)

30.00(22/74)

40.00(42/105)

41.83(64/153)

0.001

Abnormal pregnancy

13.86(37/267)

25.00 (7/28)

25.45(14/55)

20.25(16/79)

0.093

Early miscarriage rate

11.24(30/267)

14.29(4/28)

18.18(10/55)

16.46(13/79)

0.418

Late miscarriage rate

4.12(11/267)

7.14(2/28)

5.45(3/55)

2.53(2/79)

0.712

Pregnancy Complications

0

3.57(1/28)

5.45(3/55)

0

0.380

Cumulative pregnancy rate

80.91(267/330)

58.33(28/48)

75.34(55/73)

68.10(79/116)

0.001

Cumulative live birth rate

68.48(226/330)

45.83(22/48)

57.53(42/73)

55.17(64/116)

0.003

  1. PCOS: polycystic ovary syndrome; FAI: free androgen index; DHEAS: dehydroepiandrosterone sulfate. p <0.05 is considered to have significant statistical significance